CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
Novo Nordisk ObesityWeek data show CagriSema users who lost 5% by week 8 reached 25.4% weight loss at 68 weeks, ahead of an FDA decision due in Q4 2026.
Tag: cagrilintide
Read More